Historical record - last NADAC effective date: 2/22/2017
Product Information
VENLAFAXINE HCL 100 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3500 per EA under NDC 65862040820. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Apr 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862040820
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090555FDA Approved
4/7/2010
TE Code
AB
On Market Since
4/7/2010
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 100 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 19.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3500 per EA |
|---|---|
| All-time high | $0.4670 (Feb 10, 2016) |
| All-time low | $0.2895 (Oct 21, 2015) |
| Median price | $0.3549 |
| Average price | $0.3578 |
| Largest weekly change | +56.1% (Jan 20, 2016) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-19.4%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 100 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3500 per EA (NDC 65862040820), effective Feb 22, 2017.
How has the price of VENLAFAXINE HCL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 100 MG TABLET has declined 19.4%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 100 MG TABLET?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL 100 MG TABLET has ranged from a low of $0.2895 (Oct 21, 2015) to a high of $0.4670 (Feb 10, 2016), with a median of $0.3549 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 100 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VENLAFAXINE HCL 100 MG TABLET, is $0.1169 per EA — about 67% below VENLAFAXINE HCL 100 MG TABLET.
Who manufactures VENLAFAXINE HCL 100 MG TABLET?
VENLAFAXINE HCL 100 MG TABLET (NDC 65862040820) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.